APLT Research and Charts

APLT - Applied Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-10-28)

Last 1.30	Change ⇓ -0.07 (-5.11%)	Volume 1,388,881
	Open 1.27	High 1.30	Low 1.22

8EMA (Daily) 1.31	40EMA (Daily) 0.92	50EMA (Daily) 0.86	STO (Daily) 83.730	MACD Hist (Daily) -0.012
8EMA (Weekly) 1.055	40EMA (Weekly) 1.17	50EMA (Weekly) 1.40	STO (Weekly) 79.309	MACD Hist (Weekly) 0.116


Company Profile
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.